Hypoinsulinemia in a patient with isolated ACTH deficiency. 1992

H Shimizu, and S Nihei, and Y Yoshihama, and S Okamura, and N Sato, and Y Shimomura, and M Mori
First Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan.

We report on a patient with isolated ACTH deficiency accompanying deficient insulin response to glucose. The subject is a 59 year-old male. He was admitted to our hospital because of a hypoglycemic attack. Urinary excretion of 17-hydroxycorticosteroid (17-OHCS) and 17-ketosteroid (17-KS) was low. Plasma ACTH levels decreased and serum cortisol levels were undetectable. ACTH did not respond to CRF stimulation for three consecutive days. Antibodies to At-T 20 cells (anterior pituitary cell-derived cell line) were positive in the serum of this patient. Serum immunoreactive insulin (IRI) levels were not detected throughout the day. The urinary excretion of C-peptide decreased to 9.8 micrograms/day. IRI responses on 75 g oral glucose tolerance test (OGTT) were examined at one and two months after the start of cortisol supplementation. No remarkable IRI response was observed, although blood glucose levels were maintained within the normal range. Eight months after the start of cortisol supplementation, the insulin response to 75 g OGTT appeared. The present study suggests that the recovery from hypo-insulinemia may be delayed even after normalization of serum cortisol levels in ACTH deficiency. This may be possibly due to the salutary effects of cortisol in maintaining plasma insulin levels. The time lag may be due to other factors also.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic

Related Publications

H Shimizu, and S Nihei, and Y Yoshihama, and S Okamura, and N Sato, and Y Shimomura, and M Mori
January 1984, The Netherlands journal of medicine,
H Shimizu, and S Nihei, and Y Yoshihama, and S Okamura, and N Sato, and Y Shimomura, and M Mori
March 1983, Biological psychiatry,
H Shimizu, and S Nihei, and Y Yoshihama, and S Okamura, and N Sato, and Y Shimomura, and M Mori
January 2020, AACE clinical case reports,
H Shimizu, and S Nihei, and Y Yoshihama, and S Okamura, and N Sato, and Y Shimomura, and M Mori
February 2004, Medical science monitor : international medical journal of experimental and clinical research,
H Shimizu, and S Nihei, and Y Yoshihama, and S Okamura, and N Sato, and Y Shimomura, and M Mori
February 1988, The American journal of the medical sciences,
H Shimizu, and S Nihei, and Y Yoshihama, and S Okamura, and N Sato, and Y Shimomura, and M Mori
December 1996, Diabetic medicine : a journal of the British Diabetic Association,
H Shimizu, and S Nihei, and Y Yoshihama, and S Okamura, and N Sato, and Y Shimomura, and M Mori
April 2000, Clinica chimica acta; international journal of clinical chemistry,
H Shimizu, and S Nihei, and Y Yoshihama, and S Okamura, and N Sato, and Y Shimomura, and M Mori
February 1985, Journal of endocrinological investigation,
H Shimizu, and S Nihei, and Y Yoshihama, and S Okamura, and N Sato, and Y Shimomura, and M Mori
January 1993, Ryoikibetsu shokogun shirizu,
H Shimizu, and S Nihei, and Y Yoshihama, and S Okamura, and N Sato, and Y Shimomura, and M Mori
March 1976, New York state journal of medicine,
Copied contents to your clipboard!